Literature DB >> 27660581

Chagas Cardiomyopathy in New Orleans and the Southeastern United States.

Robert C Hsu1, Joshua Burak1, Sumit Tiwari1, Chayan Chakraborti1, Gary E Sander1.   

Abstract

BACKGROUND: Chagas disease (CD), caused by Trypanosoma cruzi, affects 6-7 million people worldwide annually, primarily in Central and South America, and >300,000 people in the United States. CD consists of acute and chronic stages. Hallmarks of acute CD include fever, myalgia, diaphoresis, hepatosplenomegaly, and myocarditis. Symptoms of chronic CD include pathologic involvement of the heart, esophagus, and colon. Myocardial involvement is identifiable by electrocardiogram and cardiac magnetic resonance imaging showing inflammation and left ventricular wall functional abnormalities. CASE REPORTS: We present two cases of CD identified in a single hospital in the Southeastern United States. Case 1 presents a patient with symptoms of anginal chest pain and associated shortness of breath with myocardial involvement suggestive of ischemic infarction but normal coronary arteries. Case 2 describes a patient with no physical symptoms and echocardiogram with ejection fraction of 50% with posterolateral and anterolateral wall hypokinesis but normal coronary arteries.
CONCLUSION: With a growing number of immigrants from Central and South America in the United States, it is imperative for clinicians to include CD as part of the differential diagnosis for patients presenting with heart disease who have a history of exposure to T. cruzi endemic areas.

Entities:  

Keywords:  Chagas cardiomyopathy; Chagas disease; New Orleans

Year:  2016        PMID: 27660581      PMCID: PMC5024814     

Source DB:  PubMed          Journal:  Ochsner J        ISSN: 1524-5012


  18 in total

1.  Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

Authors:  Yara M Gomes; Virginia M B Lorena; Alejandro O Luquetti
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

Review 2.  Chagas disease.

Authors:  Anis Rassi; Anis Rassi; José Antonio Marin-Neto
Journal:  Lancet       Date:  2010-04-17       Impact factor: 79.321

3.  Development and validation of a risk score for predicting death in Chagas' heart disease.

Authors:  Anis Rassi; Anis Rassi; William C Little; Sérgio S Xavier; Sérgio G Rassi; Alexandre G Rassi; Gustavo G Rassi; Alejandro Hasslocher-Moreno; Andrea S Sousa; Maurício I Scanavacca
Journal:  N Engl J Med       Date:  2006-08-24       Impact factor: 91.245

Review 4.  Trypanosoma cruzi and Chagas' Disease in the United States.

Authors:  Caryn Bern; Sonia Kjos; Michael J Yabsley; Susan P Montgomery
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy.

Authors:  Andre Talvani; Manoel O C Rocha; John Cogan; Param Maewal; James de Lemos; Antonio L P Ribeiro; Mauro M Teixeira
Journal:  Mem Inst Oswaldo Cruz       Date:  2004-11-18       Impact factor: 2.743

Review 6.  Viral infection and the pathogenesis of dilated cardiomyopathy.

Authors:  T A Martino; P Liu; M J Sole
Journal:  Circ Res       Date:  1994-02       Impact factor: 17.367

7.  Use of a rapid test on umbilical cord blood to screen for Trypanosoma cruzi infection in pregnant women in Argentina, Bolivia, Honduras, and Mexico.

Authors:  Sergio Sosa-Estani; Miriam Rubi Gamboa-León; Jaime Del Cid-Lemus; Fernando Althabe; Jackeline Alger; Olivia Almendares; María L Cafferata; Jean-Philippe Chippaux; Eric Dumonteil; Luz Gibbons; Nicolás Padilla-Raygoza; Dominique Schneider; José M Belizán; Pierre Buekens
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

8.  Physician awareness of Chagas disease, USA.

Authors:  Kelly K Stimpert; Susan P Montgomery
Journal:  Emerg Infect Dis       Date:  2010-05       Impact factor: 6.883

9.  The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease.

Authors:  J Antonio Marin-Neto; Anis Rassi; Alvaro Avezum; Antonio C Mattos; Anis Rassi; Carlos A Morillo; Sergio Sosa-Estani; Salim Yusuf
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

10.  An estimate of the burden of Chagas disease in the United States.

Authors:  Caryn Bern; Susan P Montgomery
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

View more
  2 in total

1.  Chagas Disease-induced Sudden Cardiac Arrest.

Authors:  Michael M Neeki; Michelle Park; Karan Sandhu; Kathryn Seiler; Jake Toy; Massoud Rabiei; Sasikanth Adigoupula
Journal:  Clin Pract Cases Emerg Med       Date:  2017-10-09

Review 2.  A Functional Analysis of the Cyclophilin Repertoire in the Protozoan Parasite Trypanosoma Cruzi.

Authors:  Alina E Perrone; Natalia Milduberger; Alicia G Fuchs; Patricia L Bustos; Jacqueline Bua
Journal:  Biomolecules       Date:  2018-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.